MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Striatum"

  • 2019 International Congress

    Phosphodiesterase 10A and cognition in Parkinson’s disease

    Z. Chappell, G. Pagano, H. Wilson, F. Niccolini, R. Gunn, E. Rabiner, T. Foltynie, M. Politis (London, United Kingdom)

    Objective: We aimed to assess the associations between Phosphodiesterase 10A (PDE10A) expression in the executive striatum and cognitive performance in vivo, using [11C]IMA107 PET and…
  • 2019 International Congress

    Imaging biomarker for progression of motor symptoms in advanced Parkinson’s disease

    K. Furukawa, N. Sawamoto, A. Shima, D. Kambe, A. Nishida, I. Wada, H. Sakamaki, K. Yoshimura, Y. Fushimi, T. Okada, K. Togashi, R. Takahashi (Kyoto, Japan)

    Objective: The aim of the present study is to clarify correlation between motor deficits and dopaminergic neuronal loss in advanced Parkinson’s disease (PD). Background: Series…
  • 2019 International Congress

    The Use of Diffusion Weighted Imaging to Detect Structural Biomarkers in Recently-Diagnosed Parkinson’s Disease Patients

    P. Macdonald, N. Handfield-Jones, E. Alushaj, N. Hiebert, A. Owen, A. Khan (London, ON, Canada)

    Objective: To quantify biomarkers for recently-diagnosed PD patients in the midbrain and their dopaminergic connections to the striatum. Background: The development of improved PD treatments…
  • 2019 International Congress

    7,8- Dihydroxyflavone prevents 3-NitropropionicAcid (3-NP)-induced Striatal Toxicity by Modulating the TrkB receptor and Microglial Activation Pathway

    S. Ahmed, M. Kwatra, VGM. Naidu (Kamrup, India)

    Objective: Hungtion’s disease (HD) is an autosomal governing neurodegenerative disorder caused by production of mutant hungtingtin(Htt) protein followed by death of the GABAergic neurons in…
  • 2019 International Congress

    Quercetin Regulates Cadmium Induced Motor Dysfunction in Depletion of Dopamine and its Metabolites at Synapse

    R. Gupta, RK. Shukla, AB. Pant, VK. Khanna (Lucknow, India)

    Objective: The present study has an attempt to understand cadmium induced alteration in dopamine and associated signaling that causes the motor alterations in rats and…
  • 2019 International Congress

    Toning down SPNs to improve motor responses to dopaminergic stimulation in Parkinson’s disease

    G. Beck, H. Mochizuki, S. Papa (Atlanta, GA, USA)

    Objective: This study was aimed at examining whether decreasing the baseline SPN firing frequency towards the low activity found in normal conditions reduces LID. Background:…
  • 2019 International Congress

    RNA binding protein mediated regulation of striatal transcriptome in Parkinson’s disease.

    K. Irmady, C. Hale, C. Scheckel, J. Fak, R. Darnell (New York, NY, USA)

    Objective: To investigate the role of RNA binding protein Elavl in Parkinson’s disease related adaptive changes in the striatal transcriptome. Background: Elav-like (Elavl or Hu)…
  • 2019 International Congress

    Synchronization Study of Regional Local Field Potential in Rat with Dopamine Receptor Stimulation

    SH. Lin, SY. Chen, YY. Chen (Hualien, Taiwan)

    Objective: The aim of this study attempts to explore the non-linear interaction with cross-frequency coupling in rats during the stimulation of dopamine receptors. Background: Investigating…
  • 2018 International Congress

    Emulating the natural timing of dopamine receptor activation in Parkinson’s Disease

    J. Reynolds, B. Hyland, J. Wickens, E. Tan (Dunedin, New Zealand)

    Objective: To emulate physiological dopamine receptor activation, in order to restore temporal patterns of dopamine-like signalling and normalise function in the striatum in Parkinson's disease.…
  • 2018 International Congress

    A Case of Parkinsonism due to the Hypoxic-Ischemic Lesions of the Striatum

    H. Kaleagasi, N. Oksuz, O. Dogu (Mersin, Turkey)

    Objective: To present a case of parkinsonism due to the hypoxic-ischemic lesions of the striatum. Background: Parkinsonism due to the basal ganglia lesions caused by…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 10
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley